UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031142
Receipt number R000035575
Scientific Title The effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers.
Date of disclosure of the study information 2018/04/01
Last modified on 2020/08/12 11:52:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers.

Acronym

OMSA-HBP

Scientific Title

The effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers.

Scientific Title:Acronym

OMSA-HBP

Region

Japan


Condition

Condition

Liver cancer, biliary tract cancer, pancreatic cancer

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers.

Basic objectives2

Others

Basic objectives -Others

Efficacy of oral management

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative complication
Hospital death
The days of Hospitalization stay after the operation

Key secondary outcomes

Overall survival at one year and two yaers after the operation.
Recurrence free survival at one year and two yaers after the operation.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Perioperative oral management

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers who will undergo the operation.

Key exclusion criteria

The patients who have allergies for
contrast media of CT or cannot take the CT examination because of severe renal dysfuncion.
The patients with more than 2 in perfoemance status

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Etsuro
Middle name
Last name Hatano

Organization

Hyogo College of Medicine

Division name

The department of Hepato-Bliary-Pncreatic surgery

Zip code

6638501

Address

1-1, Mukogawa town Nishinomiya city, Hyogo prefecture, Japan

TEL

0798-45-6582

Email

shatano@hyo-med.ac.jp


Public contact

Name of contact person

1st name Ikuo
Middle name
Last name Nakamura

Organization

Hyogo College of Medicine

Division name

The department of Hepato-Bliary-Pncreatic surgery

Zip code

6638501

Address

1-1, Mukogawa town Nishinomiya city, Hyogo prefecture, Japan

TEL

0798-45-6582

Homepage URL

http://www.hosp.hyo-med.ac.jp/

Email

shatano@hyo-med.ac.jp


Sponsor or person

Institute

The department of Hepato-Bliary-Pncreatic surgery, Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor

Kitano Hostital
Osaka Red Cross Hospital

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Hyogo college of Medicine

Address

1-1, Mukogawa town Nishinomiya city, Hyogo prefecture, Japan

Tel

0798456582

Email

rinri@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学              Hyogo College of Medicine
北野病院 Kitano Hospital
大阪赤十字病院 Osaka Red Cross Hospital


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 01 Day


Related information

URL releasing protocol

http://www.hosp.hyo-med.ac.jp/

Publication of results

Unpublished


Result

URL related to results and publications

http://www.hosp.hyo-med.ac.jp/

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2018 Year 03 Month 01 Day

Last follow-up date

2020 Year 10 Month 31 Day

Date of closure to data entry

2020 Year 10 Month 31 Day

Date trial data considered complete

2021 Year 10 Month 31 Day

Date analysis concluded

2025 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 02 Month 05 Day

Last modified on

2020 Year 08 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035575


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name